# A Study of AG-80308 in Dry Eye Patients

> **NCT05372107** · PHASE1 · COMPLETED · sponsor: **Allgenesis Biotherapeutics Inc.** · enrollment: 84 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** AG-80308

## Key facts

- **NCT ID:** NCT05372107
- **Lead sponsor:** Allgenesis Biotherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-13
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-02
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2022-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05372107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05372107, "A Study of AG-80308 in Dry Eye Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05372107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*